原文由 huihui3012(huihui3012) 发表:
【序号】:1
【作者(必填)】 El-Shafey, E. M.; Abdou, S. H.; Shareef, M. M.
【文题(必填)】 Is mycophenolate mofetil superior to pulse intravenous cyclophosphamide for induction therapy of proliferative lupus nephritis in Egyptian patients?
【期刊名,年份,卷(期),起止页码(必填)】Clin Exp Nephrol.2010. 14(3): p. 214-21
【全文链接或数据库名称(选填)】http://www.springerlink.com/content/yj2808u860t28670/
【序号】:2
【作者(必填)】 Sabry, A., et al. ,
【文题(必填)】 A comparative study of two intensified pulse cyclophosphamide remission-inducing regimens for diffuse proliferative lupus nephritis: an Egyptian experience.
【期刊名,年份,卷(期),起止页码(必填)】Int Urol Nephrol, 2009. 41(1): p. 153-61.
全文链接或数据库名称(选填)】http://www.springerlink.com/content/307060n21g1l3363/
【序号】:3
【作者(必填)】 Sahin, G.M., et al. ,
【文题(必填)】 Mycophenolate mofetil versus azathioprine in the maintenance therapy of lupus nephritis.
【期刊名,年份,卷(期),起止页码(必填)】Ren Fail, 2008. 30(9): p. 865-9.
【全文链接或数据库名称(选填)】http://informahealthcare.com/doi/abs/10.1080/08860220802353843
【序号】:4
【作者(必填)】 Wang, H.Y., et al. ,
【文题(必填)】 Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
【期刊名,年份,卷(期),起止页码(必填)】Lupus, 2008. 17(7): p. 638-44.
【全文链接或数据库名称(选填)】http://lup.sagepub.com/content/17/7/638.long
谢谢谢谢